Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8340)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 6, 2020 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ucciferri C, Vecchiet J, Falasca K. Role of monoclonal antibody drugs in the treatment of COVID-19. World J Clin Cases 2020; 8(19): 4280-4285 [PMID: 33083387 DOI: 10.12998/wjcc.v8.i19.4280] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i19/4280.htm |
| Number | Citing Articles |
| 1 |
Anabel Torrente-López, Jesús Hermosilla, Natalia Navas, Luis Cuadros-Rodríguez, José Cabeza, Antonio Salmerón-García. The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines 2021; 9(6): 557 doi: 10.3390/vaccines9060557
|
| 2 |
Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Mohzari, Ahmed Alrashed, Mohammed Kanan Alshammari, Mohd. Imran, Naira Nayeem. A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19. International Journal of Molecular Sciences 2021; 22(21): 11953 doi: 10.3390/ijms222111953
|
| 3 |
Serhat Karadavut, Ismail Altintop. Long-term cardiovascular adverse events in very elderly COVID-19 patients. Archives of Gerontology and Geriatrics 2022; 100: 104628 doi: 10.1016/j.archger.2022.104628
|
| 4 |
Wenkai Li, Yunjing Zhuang, Song-Jun Shao, Pankaj Trivedi, Biying Zheng, Guo-Liang Huang, Zhiwei He, Xiangning Zhang. Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review). Molecular Medicine Reports 2024; 29(3) doi: 10.3892/mmr.2024.13163
|
| 5 |
Ahmed Yaqinuddin, Areez Shafqat, Junaid Kashir, Khaled Alkattan. Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines. Vaccines 2021; 9(8): 914 doi: 10.3390/vaccines9080914
|
| 6 |
Swathy Moorthy, Teena Koshy, Mahesh K, Santhi Silambanan. Role of inflammatory and liver function markers in assessing the prognosis of patients with COVID‑19. World Academy of Sciences Journal 2021; 3(6) doi: 10.3892/wasj.2021.123
|
| 7 |
Beatrice Dufrusine, Silvia Valentinuzzi, Sandra Bibbò, Verena Damiani, Paola Lanuti, Damiana Pieragostino, Piero Del Boccio, Ersilia D’Alessandro, Alberto Rabottini, Alessandro Berghella, Nerino Allocati, Katia Falasca, Claudio Ucciferri, Francesco Mucedola, Marco Di Perna, Laura Martino, Jacopo Vecchiet, Vincenzo De Laurenzi, Enrico Dainese. Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation. International Journal of Molecular Sciences 2022; 24(1): 15 doi: 10.3390/ijms24010015
|
| 8 |
Leskovar Dunja, Pećin Ivan, Reiner Željko. Cardiovascular Complications of COVID-19. Contemporary Cardiology 2022; : 255 doi: 10.1007/978-3-031-15478-2_15
|
| 9 |
Harsh Yadav, Anand Maurya, Alka Agarwal, Anurag Kumar Singh, Satish Dubey, Aditya Moktan Tamang, Reshu Agrawal, Sushil Kumar Chaudhary. Non-traditional Approaches to Combat Antimicrobial Drug Resistance. 2023; : 57 doi: 10.1007/978-981-19-9167-7_3
|
| 10 |
Michela Pontolillo, Claudio Ucciferri, Paola Borrelli, Marta Di Nicola, Jacopo Vecchiet, Katia Falasca. Molnupiravir as an Early Treatment for COVID-19: A Real Life Study. Pathogens 2022; 11(10): 1121 doi: 10.3390/pathogens11101121
|
| 11 |
Jacek Plichta, Piotr Kuna, Michał Panek. Monoclonal Antibodies as Potential COVID-19 Therapeutic Agents. COVID 2022; 2(5): 599 doi: 10.3390/covid2050045
|
| 12 |
Jialing Yin, Chengcheng Li, Chunhong Ye, Zhihui Ruan, Yicong Liang, Yongkui Li, Jianguo Wu, Zhen Luo. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022; 20: 824 doi: 10.1016/j.csbj.2022.01.026
|
| 13 |
Ivan Delgado‑Enciso, Juan Paz‑Garcia, Carlos Barajas‑Saucedo, Karen Mokay‑Ramírez, Carmen Meza‑Robles, Rodrigo Lopez‑Flores, Marina Delgado‑Machuca, Efren Murillo‑Zamora, Jose Toscano‑Velazquez, Josuel Delgado‑Enciso, Valery Melnikov, Mireya Walle‑Guillen, Hector Galvan‑Salazar, Osiris Delgado‑Enciso, Ariana Cabrera‑Licona, Eduardo Danielewicz‑Mata, Pablo Mandujano‑Diaz, José Guzman‑Esquivel, Daniel Montes‑Galindo, Henry Perez‑Martinez, Jesus Jimenez‑Villegaz, Alejandra Hernandez‑Rangel, Patricia Montes‑Diaz, Iram Rodriguez‑Sanchez, Margarita Martinez‑Fierro, Idalia Garza‑Veloz, Daniel Tiburcio‑Jimenez, Sergio Zaizar‑Fregoso, Fidadelfo Gonzalez‑Alcaraz, Laydi Gutierrez‑Gutierrez, Luciano Diaz‑Lopez, Mario Ramirez‑Flores, Hannah Guzman‑Solorzano, Gustavo Gaytan‑Sandoval, Carlos Martinez‑Perez, Francisco Espinoza‑Gómez, Fabián Rojas‑Iarios, Michael Hirsch‑Meillon, Luz Baltazar-Rodriguez, Enrique Barrios‑Navarro, Vladimir Oviedo‑Rodriguez, Martha Mendoza‑Hernandez, Emilio Prieto‑Diaz‑Chavez, Brenda Paz‑michel. Safety and efficacy of a COVID‑19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open‑label, controlled trial. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10347
|
| 14 |
Alberto Utrero-Rico, Cecilia González-Cuadrado, Marta Chivite-Lacaba, Oscar Cabrera-Marante, Rocío Laguna-Goya, Patricia Almendro-Vazquez, Carmen Díaz-Pedroche, María Ruiz-Ruigómez, Antonio Lalueza, María Dolores Folgueira, Enrique Vázquez, Ana Quintas, Marcos J. Berges-Buxeda, Moisés Martín-Rodriguez, Ana Dopazo, Antonio Serrano-Hernández, José María Aguado, Estela Paz-Artal. Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery. Biomedicines 2021; 9(9): 1253 doi: 10.3390/biomedicines9091253
|
| 15 |
Anna Lucia Fedullo, Antonio Schiattarella, Maddalena Morlando, Anna Raguzzini, Elisabetta Toti, Pasquale De Franciscis, Ilaria Peluso. Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity. International Journal of Molecular Sciences 2021; 22(3): 1213 doi: 10.3390/ijms22031213
|
| 16 |
Paola Senia, Francesca Vella, Nicola Mucci, George Dounias, Antonio Trovato, Andrea Marconi, Caterina Ledda, Venerando Rapisarda, Ermanno Vitale. Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review. Experimental and Therapeutic Medicine 2021; 23(1) doi: 10.3892/etm.2021.10932
|
| 17 |
Xuesong He, Xiao Xue Zeng. Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?. Drug Design, Development and Therapy 2022; : 951 doi: 10.2147/DDDT.S347297
|
| 18 |
LeAnn Lopez, Peter C. Sang, Yun Tian, Yongming Sang. Dysregulated Interferon Response Underlying Severe COVID-19. Viruses 2020; 12(12): 1433 doi: 10.3390/v12121433
|
| 19 |
Georgios Giannopoulos. Fullerene Derivatives for Drug Delivery against COVID-19: A Molecular Dynamics Investigation of Dendro[60]fullerene as Nanocarrier of Molnupiravir. Nanomaterials 2022; 12(15): 2711 doi: 10.3390/nano12152711
|
| 20 |
Claudio Ucciferri, Luca Caiazzo, Marta Di Nicola, Paola Borrelli, Michela Pontolillo, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca. Parameters associated with diagnosis of COVID‐19 in emergency department. Immunity, Inflammation and Disease 2021; 9(3): 851 doi: 10.1002/iid3.440
|
| 21 |
Wei Cheng, Fen Li, Jing Tian, Xi Xie, Jin-Wei Chen, Xiao-Fei Peng, Qi Tang, Yan Ge. New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations. Journal of Inflammation Research 2022; : 2365 doi: 10.2147/JIR.S353539
|
| 22 |
Matteo Puccetti, Claudio Costantini, Maurizio Ricci, Stefano Giovagnoli. Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics. Pharmaceutics 2021; 13(4): 494 doi: 10.3390/pharmaceutics13040494
|
| 23 |
Yuan Li, Fanzhang Meng, Haixu Jiang, Qiuwei Peng, Jingyuan Fu, Dan Yin, Xiujuan Hou, Chen Li. Paradoxical skin lesions induced by IL-17 inhibitors in SAPHO syndrome. Journal of Dermatological Treatment 2024; 35(1) doi: 10.1080/09546634.2023.2295239
|
| 24 |
Marco Franzetti, Andrea Forastieri, Noemi Borsa, Alessandro Pandolfo, Chiara Molteni, Luca Borghesi, Silvia Pontiggia, Giulia Evasi, Lorenzo Guiotto, Mattia Erba, Ugo Pozzetti, Anna Ronchetti, Letizia Valsecchi, Gioacchino Castaldo, Ernesto Longoni, Daniele Colombo, Marco Soncini, Stefano Crespi, Stefano Maggiolini, Davide Guzzon, Stefania Piconi. IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study. The Journal of Immunology 2021; 206(7): 1569 doi: 10.4049/jimmunol.2001126
|
| 25 |
Shini Rubina S K, Anuba P A, Swetha B, Kavya Priya kalala, Aishwarya PM, Sarvesh Sabarathinam. Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(3): 102451 doi: 10.1016/j.dsx.2022.102451
|
| 26 |
Manuela Ceccarelli, Andrea Marino, Federica Cosentino, Vittoria Moscatt, Benedetto Celesia, Maria Gussio, Roberto Bruno, Emmanuele Rullo, Giuseppe Nunnari, Bruno Cacopardo. Post‑infectious ST elevation myocardial infarction following a COVID‑19 infection: A case report. Biomedical Reports 2021; 16(2) doi: 10.3892/br.2021.1493
|